For example, overexpression of indoleamine 2,3-dioxygenase (IDO) in tumors inhibits T cell proliferation and promotes regulatory T cell differentiation and IDO inhibitors can effectively improve the immunosuppressive microenvironment of tumors and enhance the anti-tumor immune response. Here, IDO1 is linked to neoplasm.